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Abstract Vertebrate mRNAs with a 5' terminal oligopyrimi-
dine tract (5' TOP), including those encoding ribosomal proteins 
and elongation factors, are candidates for translational control in 
a growth-dependent fashion. The present study was designed to 
determine the minimal cw-regulatory element involved in this 
mode of regulation. We selected rat P-actin mRNA, a typical 
translationally uncontrolled transcript, as a subject for gain-of-
function analysis. Mutations at and around its cap site leading to 
the formation of a 7 pyrimidines long 5' TOP render the 
resulting transcript translationally repressed upon growth arrest 
of lymphosarcoma cells. In contrast, growth-dependent transla-
tional control of this mRNA in fibroblasts requires, in addition, a 
GC motif downstream of the 5' TOP. A similar motif is present 
in all ribosomal prtein mRNAs shown to be translationally 
controlled. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The translation efficiency of m R N A s encoding several ver-
tebrate proteins associated with the translational apparatus , 
such as ribosomal proteins [1] and elongation factors E F l a 
and EF2 [2,3], is predominantly dependent on the cellular 
growth status. One feature common to all these m R N A s 
that have been rigorously analyzed thus far is the 5' terminal 
oligopyrimidine tract (TOP). This element is comprised of a 
cytidine residue at the cap site followed by an uninterrupted 
stretch of up to 13 pyrimidines [1,4,5]. Our previous attempts 
to delineate the translational cw-regulatory element (TLRE) 
were based on deletion and point mutat ions at the 5' U T R of 
several ribosomal protein (rp) m R N A s with a special empha-
sis on rpS16 m R N A . Using this loss-of-function approach we 
have established the critical role of the 5' TOP in the trans-
lational control of rp m R N A s in mammalian cells [6] and the 
strict dependence of this mode of regulation on the 5' terminal 
location of the oligopyrimidine tract [7]. 
To delimit more precisely the T L R E , we set out to address 
this issue by gain-of-function strategy. To this end, we selected 
actin m R N A , which is efficiently translated in all examined 
cell types regardless of their growth status, and therefore is 
routinely used as a negative internal reference in our and 
others ' experiments [7-9,15]. The transcription of rat P-actin 
gene starts at an A residue surrounded by four pyrimidine 
residues [10], and thus comprises a typical eukaryotic tran-
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scription start site [11]. In the present study we carried out 
systematic base substitutions at and around the cap site of this 
gene so that this region became progressively similar to the 
corresponding one in mouse rpS16. Analysis of the transla-
tional control of the various resulting transcripts in two differ-
ent cell lines has yielded the following information: (a) the 
minimal T L R E operative in cells of lymphatic origin appears 
to require no more than a 5' T O P composed of 6-8 pyrimi-
dines; (b) growth-dependent translational control in fibro-
blasts, however, requires in addition a G C motif downstream 
of the 5' T O P ; and finally (c) the selection of a specific C 
residue as a transcription start site requires its location within 
an appropriate pyrimidine stretch. 
2. Materials and methods 
2.1. Cell culture and DNA transfection 
P1798.C7 mouse lymphosarcoma cells and NIH 3T3 mouse fibro-
blasts were grown, transfected and arrested as described [7]. 
2.2. Plasmid construction 
The site-directed mutagenesis at and near the transcription start site 
of the chimeric gene Act(28)-GH [7] was carried out with the 'mega-
primer' method [12]. pAct/m(+l)-GH was constructed through the 
following steps: (a) an approximately 430-bp fragment was generated 
by PCR using the plasmid pAct(28)-GH as a template and the two 
oligonucleotides: Act-1 (5' CGGACTCGACAGGGGCTGCGCG-
TTG 3'; positions +13 to —12 of rat P-actin gene, with underlined 
letters in this and the following oligonucleotides representing substi-
tuted nucleotides) and PUC-1 (5' GTTTTCCCAGTCACGACGTT 
3'; positions 361-380 of pUC18) as primers; (b) the resulting double 
strand DNA fragment ('megaprimer') together with the primer hGH-3 
(5' CGTCCCATCTACAGGTCGCT 3 ' ; positions 123-140 of hGH 
gene) and the template pAct(28)-GH were used in a second PCR. The 
resulting ca. 570-bp fragment was cleaved by ffindlll and BamHI and 
the resulting ca. 400-bp fragment was cloned in between the Hindlll 
and BamHI sites of the promoterless plasmid pOGH [13]. The reaction 
conditions in both rounds of the PCR were with 100 ng of plasmid 
DNA and 60 ng of primers in 50 ul of 10 mM KC1, 20 mM Tris-HCl 
(pH 8.8), 10 mM ( N H ^ S O i , 2 mM MgS04 , 0.1% Triton X-100, 0.2 
mM each of the 4 dNTPs, and 1 unit of Vent DNA polymerase (New 
England Biolabs, Beverly, MA). The second PCR differed from the 
first one by inclusion of 4% dimethyl sulfoxide and 90 ng of the 
'megaprimer'. Both reactions were for 30 cycles each for 1 min at 
94°C, 2 min at 40°C and 2 min at 72°C. 
The mutant thus obtained was used as the starting material in 
sequential construction of a series of mutants using the protocol de-
scribed above. The following oligonucleotides: Act-3 (5' GACTCGA-
CAGGGAAGGCGCGTTGCGCC 3'; positions + 11 to - 1 6 of rat p-
actin gene), Act-4 (5' GCGGACTCGAAAGGGAAGGCG 3' ; posi-
tions + 14 to - 7 of rat p-actin gene), Act-5 (5' GTGGACGCG-
GACGGAAAAGGGAAGGCG 3' ; positions +20 to - 7 of rat P-
actin gene) were used in the first PCR during the construction of 
pAct/m(-4 to +1)-GH, pAct/m(-4 to +4)-GH and pAct/m(-4 to 
+8)-GH, respectively. pAct/m(+12 to +15)-GH was constructed by 
initially generating an approximately 140-bp fragment by PCR using 
the plasmid pAct/m(—4 to +8)-GH as a template and the two oligo-
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nucleotides: Act-6 (5' CCCTTTTCCGTCAATTTCCACCCGCGAG 
3' ; positions —1 to +27 of rat p-actin gne]) and hGH-3 as primers. All 
other details as described for pAct/m(+l)-GH. 
2.3. Primer extension and DNA sequencing 
Determination of the transcription start site in hGH chimeric tran-
scripts was carried out by primer extension as previously described [7]. 
Double-stranded plasmid DNA was sequenced by the dideoxy method 
[14] using a Sequenase kit (U.S. Biochemical Corp., Cleveland, OH). 
2.4. Polysomal fractionation and RNA analysis 
Harvesting and lysis of cells as well as size fractionation of poly-
somes by sedimentation through sucrose gradients were performed as 
described [15]. Northern blot analysis was performed as described 
[16]. To assess the effectiveness of the growth arrest treatment and 
the selectivity of the effect on rp mRNAs, we compared in each case 
(even if not shown) the polysomal association of a chimeric mRNA 
with that of endogenous rp mRNA and non-rp mRNA from the same 
polysomal gradient. Only experiments in which both these controls 
exhibited their typical translational behavior (repressed and unre-
pressed, respectively) were included. 
2.5. Molecular probes 
The isolated fragment probe used in the Northern blot analysis 
were: a 1.15-kb PstI fragment containing mouse a-actin cDNA 
[17]; a 0.29-kb EcoRI-Hindlll fragment containing the cDNA insert 
of mouse S16 derived from a subclone in pUC18 [18]; and a 0.8-kb 
Hindlll fragment containing a hGH cDNA (kindly provided by T. 
Fogel, Bio-Technology General). 
3. Results 
The chimeric Act(28)-GH gene is composed of human GH 
gene driven by rat P-actin promoter [7]. The resulting tran-
script starts with the first 28 nucleotides of the actin 5' UTR 
followed by the hGH sequence. The cap site of this chimeric 
mRNA is at the same A residue as in the native P-actin 
mRNA (Fig. la) [10], and like the endogenous counterpart 
it is efficiently translated, regardless of the growth status of 
the transfected PI798 or NIH 3T3 cells (Fig. 2, lines 1 and 2) 
[7]. Interestingly, 12 nucleotides within the rat P-actin gene, 
spanning positions —4 to +28, also appear at the correspond-
ing positions in the mouse rpS16 gene (Fig. 2, line 2). Hence, a 
relatively small number of substitutions are required to com-
pletely transform this actin sequence into the corresponding 
rpS16 sequence. Consequently, we set out to progressively 
perform such a transformation and to monitor at each step 
both the cap site and the translational behavior of the result-
Table 1 
GC motifs immediately downstream of the 5' TOP within mammali-
an rp mRNAs shown to be translationally controlled in a growth-
dependent manner 
Protein Sequence 
5' TOP Accession 
(nucU Number 
+1 10 20 30 
I I I 1 
m rpL13a CUUUCCCAGGCGGCUGCCGAAG 
m rpL30 CCUUUCUCGCUCCCCGGCCGUCUUGGCGGC 
m rpL32 CUUCUUCCUCGGCGCUGCCUACGAGGUGGC 
m rpS4 CUCUUDCCGUUCCUAGCGCAGCC 
m rpS16 CCUUUUCCGGUCGCGGCGCUGCGGUGUGGA 
r rpP2 CUUUCGCCGCCGGACGCCGCCGAGGUCGCA 
h rpS4Y CUCUUCCGUCGCAGAGUUUCGCC 
h rpS4X CCUCUUUCCUUGCCUAACGCAGCC 
h rpS6 CCUCUUUUCCGUGGCGCCUCGGAGGCGUUC 
7 
8 
10 
8 
8 
5 
7 
11 
10 
X51528 
K02928 
K02060 
L24371 
Ml 1408 
X55153 
L24370 
L24369 
X67309 
Sequences presented in this table represent only mRNAs whose cap 
site has been rigorously determined. Underlined letters, GC motifs; 
m, mouse; r, rat; h, human. 
Fig. 1. Determination of the transcription start site of various hGH 
chimeric mRNAs by primer extension. A 5' end labeled synthetic 
oligonucleotide complementary to nucleotides +31 to +12 of hGH 
gene was annealed to 0.5-5 |xg of poly(A)+ mRNA from stably 
transfected NIH 3T3 and extended with AMV reverse transcriptase. 
The extended product (P) was analyzed on a 6% acrylamide-urea 
gel alongside with a dideoxy sequencing reaction (A, C, G, T), in 
which the same primer (unlabeled) was used. Large and small aster-
isks indicate major and minor transcription start sites, respectively. 
ing transcript. A transcript is considered translationally con-
trolled if it is converted from mostly polysome-associated in 
growing cells to mostly subpolysome-associated in resting 
cells. 
Initially, we replaced the A residue at the cap site by a C 
residue [Act/m(+l)-GH]. This mutation did not render the 
resulting transcript translationally controlled (Fig. 2, line 3), 
even though the major transcription start sites were at a C 
and a T residue at positions +2 and +3, respectively (Fig. lb). 
Next, we substituted the three nucleotides at positions —4 to 
—2 by the corresponding nucleotides from rpS16 sequence 
[Act/m(—4 to +1)-GH]. However, this alteration neither led 
to the selection of any of the C residues at positions — 1 to +2 
as the major transcription start sites (Fig. lc), as in the case of 
rpS16 gene, nor did it confer translational regulation on the 
respective transcript (Fig. 2, line 4). Surprisingly, a substitu-
tion of only one additional nucleotide, a G to T at position +4 
[Act/m(—4 to +4)-GH], sufficed to render the resulting tran-
scripts translationally repressed upon growth arrest of both 
cell lines (Fig. 2, line 5). The milder repression of these tran-
scripts in comparison with that displayed by the endogenous 
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P1798 NIH 3T3 
G NG 
P S P S 
NG 
P S P 
1) Endogenous Actin 
+1 +10 +20 
2) Act(28)-GH agcCaCTgTcgaGtC.CGCG^CgagggGgflagt 
FT 
3) Act/m(+l)-GH as£CCCTgT£aaG££CGCG£.C£a££ffG£gflg£ 
] * * 
4) Act/m(-4 to+1)-GH CTTCCCTgT£gaGt£CGCGtCcaccCGcgagt 
5) Act/m(-4 to +4)-GH CTTCCCrrT£^G££CGCG£C£a££ffG£gagJk 
6) Act/m(-4 to+8)-GH CTTCCCTTTTCCG££CGCG£C£a££S:G£gaa£ 
7)Act/m(+12to+15)-GH rTTTCCTTTTCCGtr;!fTWtCcaccCGcaaQt 
8) Endogenous rpS16 CTTCCCTTTTCCGGTCGCGGCGCTGCGGTGTG 
Fig. 2. The effect of the number of pyrimidines within the 5' TOP and of the downstream GC sequence on the translational control in different 
cell lines. PI 798 and NIH 3T3 cells were transiently and stably transfected, respectively, with the indicated hGH chimeric genes. Cytoplasmic 
extracts were prepared from growing (G) cells (untreated PI 798 and NIH 3T3 cells) and from nongrowing (NG) cells (24-h dexamethasone-
treated P1798 cells and 24-h aphidicolin-treated NIH 3T3 cells), centrifuged through sucrose gradients and separated into polysomal (P) and 
subpolysomal (S) fractions. Poly(A)+ mRNA from equivalent aliquots of these fractions was analyzed by Northern blot hybridization. Analysis 
of the endogenous rpS16 mRNA or actin mRNA and the chimeric hGH mRNA was performed with the respective probes. The sequences at 
the left of the autoradiograms represent the nucleotides around the major transcription start sites (marked by arrows). Actin sequences which 
are identical with the corresponding nucleotides within the rpS16 sequence appear in underlined lowercase letters, whereas actin-specific sequen-
ces appear in bold uppercase letters. Shadowed letters depict substituted nucleotides which do not correspond to any of these mRNAs. Results 
obtained with PI 798 cells and presented in lines 1-3 and 5-8 represent at least two independent experiments. Results obtained with NIH 3T3 
cells and presented in lines 1 and 5-8 represent at least two independent experiments. 
rpS16 mRNA (Fig. 2, line 8) might reflect the fact that third 
of the former starts at a T residue rather than a C residue 
(Fig. Id). In Act/m(—4 to +8)-GH actin sequence spanning 
positions —4 to +8 was converted to the corresponding rpS16 
sequence by the appropriate base substitutions. The corre-
sponding transcripts displayed both selection of the same 
three C residues as cap sites (Fig. le) and a similar transla-
tional behavior as exhibited by endogenous rpS16 mRNA 
(Fig. 2, line 6). 
The Act/m(—4 to +4)-GH transcript contains a 6-8 residues 
long 5' TOP, which appears to provide the requirement both 
for the selection of the appropriate transcription start sites 
and for the TLRE. Nevertheless, we have previously shown 
that sequences residing downstream of the 5' TOP of rpS16 
are necessary for translational control, at least in NIH 3T3 
cells [7]. Close inspection of the sequence of actin mRNA 
between positions +5 to +28 has disclosed 8 positions in 
which it shares the same nucleotides with rpS16 mRNAs, 
with a notable identity of the sequence CGCG at positions 
+12 to +15. To verify whether this tetramer plays any role in 
the translational control, we substituted it in Act/m(—4 to 
+8)-GH by an AATT sequence to yield the mutant Act/ 
m(+12 to +15)-GH. The resulting chimeric mRNA exhibited 
the typical growth-dependent translational control in PI798 
lymphosarcoma cells, but remains mostly in polysomes in 
growth arrested NIH 3T3 cells (Fig. 2, line 7). 
4. Discussion 
In the present report we have demonstrated that the first 6-
8 pyrimidine residues suffice for a 5' TOP to be functional in 
translational regulation. The requirement for such a relatively 
short pyrimidine stretch is not unprecedented, as rat rpP2 
mRNA which contains a five pyrimidines long 5' TOP [19] 
is translationally regulated to the same extent as rp mRNAs 
with a longer pyrimidine stretch [20]. More surprising, how-
ever, is our present observation that a functional TLRE in 
lymphosarcoma cells appears to need no more than the min-
imal 5' TOP (Act/m(+12 to +15)-GH in Fig. 2). Conceivably, 
the difference in the mode of transfection into NIH 3T3 cells 
(stable) or PI798 cells (transient) cannot account for the loss 
of translational control of this mRNA in NIH 3T3 cells, as we 
have recently observed a selective loss of translational regu-
lation of a similar mutant in fibroblasts regardless of their 
mode of transfection (Avni et al., manuscript submitted). 
Nevertheless, these results are consistent with those obtained 
in recent loss-of-function experiments, in which we deleted 
nucleotides spanning positions 11-29 or replaced nucleotides 
spanning positions 7-16 within the 5' UTR of rpS16. These 
modifications led to the differential loss of translational con-
trol of the resulting transcripts in fibroblasts but not in lym-
phosarcoma cells (Avni et al., manuscript submitted). Based 
on these two complementary approaches, it appears that our 
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previous conclusion that sequences immediately downstream 
of the 5' TOP are essential for growth-dependent translational 
control in fibroblasts [7] should not be extended to cells of 
lymphatic origin. 
The conserved nucleotides within the 5' UTR of mRNAs 
encoding mouse rpS16 and rat P-actin have enabled us to 
identify a CG motif, within the region immediately down-
stream of the 5' TOP, which is essential for translational 
control in fibroblasts. Table 1 shows that similar motifs are 
present in comparable locations of other mammalian rp 
mRNAs, known to be translationally controlled in a 
growth-dependent fashion. Clearly, except for the general 
composition neither the 5' TOPs nor the GC motifs are con-
served among different rp mRNAs. Conceivably, optimal 
TLRE composition can be achieved by different combinations 
of the pyrimidine stretch and the GC motifis). This notion is 
supported by our previous observation that sequences down-
stream of rpS16 5' TOP failed to replace the corresponding 
missing sequences in truncated rpL32 TLRE [7]. It should be 
pointed out, however, that none of the TLREs examined so 
far contains a significantly stable hairpin structure involving 
the GC motif. 
Our current working hypothesis is that the 5' TOP interacts 
with a trans-acting factor and the avidity of this interaction 
depends on the structure of the TLRE which varies among 
different mRNAs. In accordance with this assumption, any 
structural modification in the TLRE and/or in the abundance 
of the trans-acting factor might affect the intensity of the 
interaction between the two and hence the sensitivity to alter-
ations in the growth status. This notion is supported by the 
differential behaviour of Act/m(+12 to +15)-GH mRNA (Fig. 
2, line 7). Thus, if the abundance of the trans-acting factor 
differs between hematopoietic cells and fibroblasts and if 
downstream mutations affect the affinity of this factor to the 
5' TOP, then the respective base substitution will be more 
critical in one cell line than in the other. 
Many of the mammalian TOP genes examined so far lack a 
well defined TATA box, yet they initiate transcription with a 
high precision within an 'initiator' element, which is composed 
of an uninterrupted stretch of pyrimidines [1]. It should be 
emphasized that initiation of transcription at a C residue is a 
relatively rare event (about 17% [21]) among eukaryotic genes, 
which in most reported cases is at an A residue [11]. We have 
previously shown that C to A replacements at the cap site of 
rp promoters or at its immediate vicinity dictated the selection 
of the purine residue as the transcription start site, and con-
sequently to the loss of translational control of the resulting 
mRNA [7]. The promoter of rat (3-actin gene contains a typ-
ical TATA box, yet replacement of the A residue at the cap 
site by a C residue does not attract RNA polymerase II to 
initiate at this residue, even though it is surrounded by four 
pyrimidines. It is not before this residue is followed by five 
pyrimidines that it is selected as a transcription start site (Fig. 
2, line 5). Moreover, selection of three consecutive C residues 
as cap sites, as in the case of endogenous rpS16 mRNA, is 
observed only when the eight-pyrimidine 5' TOP of rp S16 
mRNA is generated in the chimeric construct (Fig. 2, line 6). 
It appears, therefore, that the definition of the initiator ele-
ment as "a DNA sequence that overlaps a transcription start 
site and which is sufficient for determining the start site loca-
tion in a promoter that lacks a canonical TATA box" [22] 
should be extended to include promoters that do contain such 
a box. 
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